Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, how many covid-19 vaccines his Department has ordered for delivery in each year of the next five years.

The UK government has secured early access to 332 million vaccines doses through supply agreements with five separate vaccine developers. This includes agreements with:

• Pfizer/BioNTech for 135​ million doses
• University of Oxford/AstraZeneca for 100 million doses
• Moderna for 17 million doses
• Novavax for 60 million doses
• Janssen for 20 million doses

Of these, Pfizer/BioNTech, University of Oxford/AstraZeneca and Moderna vaccines have received MHRA regulatory approval and are currently in deployment in the UK. The Janssen vaccine has also received regulatory approval and deliveries are expected later this year. The Novavax vaccine is yet to receive regulatory approval, so timings for delivery are dependent on this.

Due to commercial sensitivities, we are not able to provide detailed timelines for delivery.

We are in regular contact with the vaccine manufacturers and are confident in our vaccine supplies going into the autumn/ winter, having already secured the doses we need for everyone in the UK who requires a booster.